Home / Investors / Startups / Kineta

Kineta

Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.

About Kineta

Kineta is a biotechnology company engaging in the discovery and development of antiviral therapies and immune-modulating drugs for the treatment of RNA viruses that include hepatitis C, influenza, West Nile virus, and the common cold. Kineta was founded in 2008 and is based in Seattle, Washington.

Industries

Investors in Kineta (4)